Collegium Pharmaceutical (NASDAQ:COLL): Q2 GAAP EPS of -$0.14 beats by $0.05.
Revenue of $75.04M (+2.7% Y/Y) misses by $0.73M.
Shares -2.26%.
Wednesday, August 7, 2019
Radius Health EPS beats by $0.21, beats on revenue
Radius Health (NASDAQ:RDUS): Q2 Non-GAAP EPS of -$0.55 beats by $0.21; GAAP EPS of -$0.77 beats by $0.10.
Revenue of $41M (+81.2% Y/Y) beats by $0.4M.
Cara Therapeutics EPS beats by $0.03, beats on revenue
Cara Therapeutics (NASDAQ:CARA): Q2 GAAP EPS of -$0.58 beats by $0.03.
Revenue of $5.2M (+79.3% Y/Y) beats by $0.11M.
Aerie Pharmaceuticals EPS beats by $0.08, beats on revenue
Aerie Pharmaceuticals (NASDAQ:AERI): Q2 Non-GAAP EPS of -$0.80 beats by $0.08; GAAP EPS of -$1.04 misses by $0.05.
Revenue of $15.84M (+554.5% Y/Y) beats by $0.88M.
Shares -10.56%.
Regenxbio EPS beats by $0.71, beats on revenue
Regenxbio (NASDAQ:RGNX): Q2 GAAP EPS of -$0.04 beats by $0.71.
Revenue of $7.88M (-80.4% Y/Y) beats by $2.43M.
Amphastar Pharmaceuticals EPS beats by $0.03, beats on revenue
Amphastar Pharmaceuticals (NASDAQ:AMPH): Q2 Non-GAAP EPS of $0.08 beats by $0.03; GAAP EPS of $0.96.
Revenue of $79.05M (+11.3% Y/Y) beats by $0.15M.
Glaukos EPS misses by $0.09, beats on revenue
Glaukos (NYSE:GKOS): Q2 GAAP EPS of -$0.17 misses by $0.09.
Revenue of $58.6M (+35.8% Y/Y) beats by $2.36M.
Shares -5.61%.
Subscribe to:
Posts (Atom)